Clinical Trials: Importance, Apprehensions, and Barriers
Date & Time: Wednesday, November 18, 2026 · 4:00–5:00 PM EST
Speakers: Dr. Mélina Boutin and Mathieu Lebeau
Location:
Online
Description
Clinical trials give patients the opportunity to access new treatments or new combinations of treatments. For lymphoma and CLL patients, clinical trials can provide access to therapies not yet available in Canada. This webinar explores the importance of clinical trials, how to access them, and the challenges associated with participation — such as apprehensions and access barriers. Please note that this presentation offers a general overview of clinical trials, including examples of how patients can access new treatments. This webinar is intended for patients, caregivers, and anyone wishing to better understand clinical trials.
Speaker Bios:
Dr. Mélina Boutin is a hematologist-oncologist at the Montérégie Integrated Oncology Centre at Charles-Le Moyne Hospital and Associate Director of Clinical Research at the Charles-Le Moyne Research Centre. With over thirteen years of experience as an oncologist and hematologist, she is actively involved in clinical oncology research, including work focused on patients with hematological cancers. Her research on the efficacy and safety of COVID-19 vaccination in cancer patients was recognized with the 2022 Cancer Care Award in the “Health Promotion and Prevention” category of the Quebec Cancer Program.
Mathieu Lebeau is a clinical research coordinator in oncology at Charles-Le Moyne Hospital. He holds a graduate diploma in drug development (DESS) specializing in clinical research and a master’s degree in pharmaceutical sciences from Université de Montréal. He has worked for several years in oncology research and participates in initiatives to improve access to and participation in clinical trials. He has presented on various clinical research issues, including the benefits and risks of clinical trials, barriers to participation, and the myths and perceptions surrounding research.
